CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Generics

GENERICS

Life-saving solutions
that are cost-saving

Innovative science and an entrepreneurial culture drive us to develop path-breaking therapies. But it is our commitment to transform lives that  pushes us further, to put medicines that are safe, effective and affordable, within patients’ reach. Generics offer an equally safe and effective option as their branded counterparts as well as substantial savings.

null

Generics offer an equally safe and effective option as their branded counterparts as well as substantial savings.

null

If more prescribers substituted generics for brand-name drugs, drug spending could drop substantially. Keeping with this mission, Biocon is focused on delivering a basket of quality products to patients, partners and healthcare systems across the globe.

The Generics market today

The US Food and Drug Administration (FDA) describes a generic drug as, “a medication created to be the same as an already marketed brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.”

Generic drugs account for about two-thirds of prescriptions filled in the United States. Developing a new drug can take up to 15 years or more and cost up to $5 billion. A patent life varies from country to country, but can last up to 20 years. In comparison, the cost savings offered by generic drugs position them as a better option as they are equally safe and effective. They also reduce the burden of healthcare costs for patients, providers and healthcare systems. If more prescribers substituted generics for brand-name drugs, drug spending could drop substantially. Keeping with this mission, Biocon is focused on delivering a basket of quality products to patients, partners and healthcare systems across the globe.

Symbiotic partnerships with innovators

We firmly believe that everyone has the right to affordable, accessible healthcare. We are passionate about developing affordable treatments that can transform patients’ lives. This propels us to go beyond our universe and collaborate with partners with cutting-edge technologies that can deliver quality and reliability for our products. Partnerships give us the advantages of optimising manufacturing and commercialisation costs and accelerating scalability.

null

Partnerships give us the advantages of optimising manufacturing and commercialisation costs and accelerating scalability.

Business Segments

Aiming to fulfil the global demand for Generics

Our Strengths

MANUFACTURING
OPERATIONS

RESEARCH &
DEVELOPMENT

QUALITY &
COMPLIANCE

Siddharth Mittal
KEY MANAGEMENT TEAM
PRODUCTS
PRESS RELEASES
CORPORATE GOVERNANCE
R&D
WORKING WITH US
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>